Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension-Reference-Cited by-同舟云学术

Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension

Published:2016-06 Issue:6 Volume:36 Page:1293-1301
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:Arterioscler Thromb Vasc Biol.

Author:

Yaoita Nobuhiro¹,Satoh Kimio¹,Satoh Taijyu¹,Sugimura Koichiro¹,Tatebe Shunsuke¹,Yamamoto Saori¹,Aoki Tatsuo¹,Miura Masanobu¹,Miyata Satoshi¹,Kawamura Takeshi¹,Horiuchi Hisanori¹,Fukumoto Yoshihiro¹,Shimokawa Hiroaki¹

Affiliation:

1. From the Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (N.Y., K. Satoh, T.S., K. Sugimura, S.T., S.Y., T.A., M.M., S.M., Y.F., H.S.), Clinical Pharmaceutics educational Center, Nihon Pharmaceutical University, Saitama, Japan (T.K.); and Department of Molecular and Cellular Biology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan (H.H.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism

2. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

3. Optical Coherence Tomography as a Novel Diagnostic Tool for Distal Type Chronic Thromboembolic Pulmonary Hypertension

4. Optical Coherence Tomography Is Superior to Intravascular Ultrasound for Diagnosis of Distal-Type Chronic Thromboembolic Pulmonary Hypertension

5. Recent Progress in the Management of Pulmonary Hypertension

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach;Circulation;2024-09-10

2. Assessment of thrombin-activatable fibrinolysis inhibitor levels in essential hypertension;The European Research Journal;2024-08-21

3. Chronic Thromboembolic Pulmonary Hypertension: A Review of the Multifaceted Pathobiology;Biomedicines;2023-12-24

4. Serum Proteomics Identified TAFI as a Potential Molecule Facilitating the Migration of Peripheral Monocytes to Damaged White Matter During Chronic Cerebral Hypoperfusion;Neurochemical Research;2023-11-17

5. The relationship between activation of the coagulo‑fibrinolytic system and aseptic inflammation in patients with long‑term chronic thromboembolic pulmonary hypertension;"Arterial’naya Gipertenziya" ("Arterial Hypertension");2023-07-26